Merus Labs International Inc (MSL) Given Average Rating of “Hold” by Brokerages
Merus Labs International Inc (TSE:MSL) (NASDAQ:MSLI) has received an average recommendation of “Hold” from the seven research firms that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is C$1.99.
A number of equities analysts have issued reports on MSL shares. TD Securities cut their price target on Merus Labs International from C$3.00 to C$1.65 and set a “tender” rating on the stock in a report on Friday, May 12th. Scotiabank increased their price target on Merus Labs International from C$1.25 to C$1.65 and gave the stock a “sector perform” rating in a report on Friday, May 12th. Finally, CIBC increased their price target on Merus Labs International from C$1.40 to C$1.65 in a report on Monday, May 15th.
Merus Labs International (TSE:MSL) traded up 0.61% during mid-day trading on Friday, hitting $1.65. 381,175 shares of the stock were exchanged. Merus Labs International has a 1-year low of $0.95 and a 1-year high of $1.76. The stock has a 50 day moving average price of $1.62 and a 200 day moving average price of $1.25. The company’s market capitalization is $193.64 million.
About Merus Labs International
Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.
Receive News & Ratings for Merus Labs International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International Inc and related companies with MarketBeat.com's FREE daily email newsletter.